Clinical outcomes in diabetic and non-diabetic patients with drug-eluting stents: Results from the first phase of the prospective multicenter German DES.DE registry

Clinical Research in Cardiology

Volumn 99, Issue 6, 2010, Pages 393-400

  Akin, Ibrahim ^a   Bufe, Alexander ^b   Schneider, Steffen ^c   Reinecke, Holger ^d   Eckardt, Lars ^d   Richardt, Gert ^e   Burska, Detlev ^a   Senges, Jochen ^c   Kuck, Karl Heinz ^f   Nienaber, Christoph A ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

^c Heart Center Ludwigshafen   (Germany)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^e Rehabilitationszentrum Bad Segeberg   (Germany)

^f Asklepios Clinic Altona   (Germany)

Author keywords

Diabetes mellitus; PCI; Registry; Restenosis; Stent thrombosis

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE REGISTRY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; GERMANY; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PROSPECTIVE STUDY; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; STROKE; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS; COMPARATIVE STUDY; CORONARY RESTENOSIS; DIABETIC ANGIOPATHY; MIDDLE AGED; REGISTER;

AGED; CORONARY RESTENOSIS; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DRUG-ELUTING STENTS; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; REGISTRIES; TREATMENT OUTCOME;

EID: 77954656576     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-010-0136-8     Document Type: Article

References (27)

1. Bonow RO, Gheorghiade M (2004) The diabetes epidemic: a national and global crisis. Am J Med 116(Suppl 5A):2S-10S
2. Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jönsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL, Deckers JW, Bertrand M, Charbonnel B, Erdmann E, Ferrannini E, Flyvbjerg A, Gohlke H, Juanatey JR, Graham I, Monteiro PF, Parhofer K, Pyörälä K, Raz I, Schernthaner G, Volpe M, Wood D (2007) Guidelines on diabetes, pre-diabetes, and cardiovascular diseases. The Task Force and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for Study of Diabetes (EASD). Eur Heart J 28:88-136
3. Drechsler K, Fikenzer S, Sechtem U, Blank E, Breithardt G, Zeymer U, Nienabuer J (2008) The EuroHeart Survey- Germany: diabetes mellitus remains unrecognized in patients with coronary artery disease. Clin Res Cardiol 97(6):364-370
4. Abizaid A, Kornowski R, Mintz GS, Hong MK, Abizaid AS, Mehran R, Pichard AD, Kent KM, Satler LF, Wu H, Popma JJ, Leon MB (1998) The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 32:584-589
5. Frye RL, August P, Brooks MM, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, Orchard TJ, Chaitman BR, Genuth SM, Goldberg SH, Hlatky MA, Jones TL, Molitch ME, Nesto RW, Sako EY, Sobel BE, BARI 2D Study Group (2009) A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 360(24):2503-2515
6. Abizaid A, Costa MA, Centemero M, Abizaid AS, Legrand VM, Limet RV, Schuler G, Mohr FW, Lindeboom W, Sousa AG, Sousa JE, van Hout B, Hugenholtz PG, Unger F, Serruys PW, Arterial Revascularization Therapy Study Group (2001) Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients. Insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation 104:533-538
7. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, Jüni P (2007) Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370:937-948 (Pubitemid 47393576)
8. Mahmud E, Bromberg-Marin G, Palakodeti V, Ang L, Creanga D, Demaria AN (2008) Clinical efficacy of drug-eluting stents in diabetic patients. J Am Coll Cardiol 51:2385-2395
9. Moussa I, Leon MB, Baim DS, O'Neill WW, Popma JJ, Buchbinder M, Midwall J, Simonton CA, Keim E, Wang P, Kuntz RE, Moses JW (2004) Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 109:2273-2278
10. Hermiller JB, Raizner A, Cannon L, Gurbel PA, Kutcher MA, Wong SC, Russell ME, Ellis SG, Mehran R, Stone GW, TAXUS-IV Investigators (2005) Outcomes with the polymerbased paclitaxel-eluting TAXUS stent in patients with diabetes mellitus. The TAXUS-IV trial. J Am Coll Cardiol 45:1172-1179 (Pubitemid 40523133)
11. Stettler C, Allemann S, Wandel S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, De Carlo M, Erglis A, Chechi T, Ortolani P, Schalij MJ, Diem P, Meier B, Windecker S, Jüni P (2008) Drug-eluting and bare metal stents in people with and without diabetes: collaborative network metaanalysis. BMJ 337:a1331
12. Dibra A, Kastrati A, Mehilli J, Pache J, Schühlen H, von Beckerath N, Ulm K, Wessely R, Dirschinger J, Schömig A, ISAR-DIABETES Study Investigators (2005) Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 353:663-670
13. Jiménez-Quevedo P, Sabaté M, Angiolillo DJ, Alfonso F, Hernández-Antolín R, SanMartín M, Gómez-Hospital JA, Ban ̃uelos C, Escaned J, Moreno R, Fernández C, Fernández-Avilés F, Macaya C, Alfonso F, Hernández- Antolín R, SanMartín M, DIABETES Investigators et al (2007) Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial. Eur Heart J 28:1946-1952
14. Ortolani P, Ardissino D, Cavallini C, Bramucci E, Indolfi C, Aquilina M, Marzocci A (2005) Effect of sirolimus-eluting stent in diabetic patients with small coronary arteries (A SES-SMART Substudy). Am J Cardiol 96:1393-1398
15. Silber S, Albertsson P, Avilles FF, Camici PG, Colombo A, Hamm C, Jørgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W, Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology (2005) Guidelines for percutaneous coronary interventions: the task force for percutaneous coronary interventions of the European society of cardiology. Eur Heart J 26:804-847
16. World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complication: report of a WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus. World Health Organization, Geneva
17. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW, Academic Research Consortium (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115:2344-2351
18. Baumgart D, Klauss V, Baer F, Hartmann F, Drexler H, Motz W, Klues H, Hofmann S, Völker W, Pfannebecker T, Stoll HP, Nickenig G, SCORPIUS Study Investigators (2007) One-year results of the SCORPIUS study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients. J Am Coll Cardiol 50:1627-1634
19. Garg P, Normand SHT, Silbaugh TS, Wolf RE, Zelevinsky K, Lovett A, Varma MR, Zhou Z, Mauri L (2008) Drug-eluting or bare-metal stenting in patients with diabetes mellitus. Results from the Massachusetts Data Analysis Center Registry. Circulation 118:2277-2285
20. Weber FD, Schneider H, Wiemer M, Pfannebecker T, Tebbe U, Hamm CW, Senges J, Schneider S, Nienaber CA (2008) Sirolimus- eluting stent (Cypher) in patients with diabetes mellitus: results from the German Cypher Stent Registry. Clin Res Cardiol 97(2):105-109
21. Schuhlen H, Kastrati A, Dirschinger J, Hausleiter J, Elezi S, Wehinger A, Pache J, Hadamitzky M, Schömig A (1998) Intracoronary stenting and risk for major adverse events during the first month. Circulation 98:104-111
22. Ong AT, Serruys PW, Aoki J, Hoye A, van Mieghem CA, Rodriguez-Granillo GA, Valgimigli M, Sonnenschein K, Regar E, van der Ent M, de Jaegere PP, McFadden EP, Sianos G, van der Giessen WJ, de Feyter PJ, van Domburg RT (2005) The unrestricted use of paclitaxel-versus sirolimus-eluting stents for coronary artery disease in an unrestricted population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry. J Am Coll Cardiol 45:1135-1141
23. Iakovou I, Schmidt T, Bonizzoni E, GE L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293:2126-2130
24. Machecourt J, Danchin N, Leblanche JM, Fauvel JM, Bonnet JL, Marliere S, Foote A, Quesada JL, Eltchaninoff H, Vanzetto G, EVASTENT Investigators (2007) Rsik factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients. The EVASTENT matched-cohort registry. J Am Coll Cardiol 50:501-508
25. Hoffmann R, Klinker H, Adamu U, Kelm M, Blindt R (2009) The risk of definitive stent thrombosis is increased after "off-label" stent implantation irrespective of drug-eluting stent or bare-metal stent use. Clin Res Cardiol 98(9):549-554
26. Evangelista V, Totani L, Rotondo S, Lorenzet R, Tognoni G, De Berardis G, Nicolucci A (2005) Prevention of cardiovascular disease in type-2 diabetes: how to improve the clinical efficacy of aspirin. Thromb Haemost 93:8-16
27. Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW (2007) A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356:989-997